Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 30, Issue 4, 2007, Pages 197-210

  Ghaemi, Amir ^a   Soleimanjahi, Hoorieh ^b   Bamdad, Taravat ^b   Soudi, Sara ^b   Arefeian, Ehsan ^b   Hashemi, Seyed Mahmood ^b   Ebtekar, Massoumeh ^b  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Cellular immunity; DNA vaccine; Herpes simplex virus type 1; Humoral immunity; Latency

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; HERPES SIMPLEX VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CLINICAL EVALUATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DNA IMMUNIZATION; FEMALE; HERPES SIMPLEX VIRUS 1; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INFECTION PREVENTION; LATENT VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PROVOCATION TEST; SENSORY NERVE; SURVIVAL RATE; VIRUS LATENCY; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGEMINAL GANGLION; VACCINES, DNA; VIRUS LATENCY;

HUMAN HERPESVIRUS 1; MUS; SIMPLEXVIRUS;

EID: 34249741641     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2007.01.002     Document Type: Article

References (22)

1. Roizman B., and Sears A.E. An inquiry into the mechanisms of Herpes simplex virus latency. Annul Rev Microbiol 41 (1987) 543-571
2. Lin W.R., Jennings R., Smith T.L., Wozniak M.A., and Itzhaki R.F. Vaccination prevents latent HSV-1 infection of mouse brain. Neurobiol Aging 2 (2001) 699-703
3. Feldman L.T., Ellison C.C., Voytek L., Krause P.Y., and Margolis T.P. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci USA 99 (2002) 978-983
4. Strasser J.E., Arnold R.L., Pachuk C., Higgins T.J., and Bernstein D.I. Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein d plasmid constructs. J Infect Dis 182 (2000) 1304-1310
5. Stanbery L.R., Cunningham A.L., Mindel A., Scott L.L., Spruance S.L., and Aok F.Y. Prospect for control of Herpes simplex virus diseases through immunization. Clin Infect Dis 30 (2000) 549-599
6. Manickan E., Rouse R.J.D., Yu Z., Wire W.S., and Rouse B.T. Genetic immunization against herpes simplex virus: protection is mediated by CD4+ T lymphocytes. J Immunol 155 (1995) 259-265
7. Frye T.D., Chiou H.C., Hull B.E., and Bigley N.J. The efficacy of a DNA vaccine encoding Herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge. Arch Virol 147 (2002) 1747-1759
8. Baghian A., Chouljeko V.N., Dauvergne O., Newman M.J., Baghian S., and Kousoulask G. Protective immunity against lethal HSV-1 challenges in mice by nucleic acid- Based immunization with Herpes simplex virus-1 genes specifying glycoproteins gB and gD. J Med Microbiol 51 (2002) 350-357
9. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., and Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, GH and gI): comparative protection against lethal challenge in mice. J Virol 68 4 (1994) 2118-2126
10. Soleimanjahi H., Roostaee M.H., Rasaee M.J., Mahboudi F., Kazemnejad A., Bamdad T., et al. The effect of DNA priming-protein boosting in enhancing The humoral immunity and protecting mice against lethal HSV infections. FEMS Immunol Med Microbiol 46 1 (2006) 100-106
11. Sambrook J., and Russell D.W. Molecular cloning: a laboratory manual. 3rd ed (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
12. Karcher SJ. Recombinant DNA cloning. In: molecular biology-a project approach. New York: Academic press; 1997. p. 72-131 [Chapter 2].
13. Inoue T., Inoue Y., and Nakamura T. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. Invest Ophthalmol Vis Sci 41 (2000) 4209-4215
14. Ramakrishan R., Fink D.J., Jiang G., Desai P., Glorioso J.C., and Levine M. Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency associated transcript RNA in latently infected cells of the rat brain. J Virol 68 (1994) 1864-1873
15. Rogers J.V., Hull B.E., Fink P.S., Chiou H.C., and Bigley N.J. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver. vaccine 18 (2000) 1522-1530
16. Mikloska A., and Cunningham A.L. Herpes simplex virus type 1glycoproteins gB, gC, and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J Gen Virol 79 (1998) 353-361
17. Bourne N., Milligan G.N., Schleiss M.R., Bernstein D.I., and Stanberrry R. DNA immunization confers protective immunity on mice challenged intravaginally with Herpes simplex virus type 2. Vaccine 14 (1996) 1230-1234
18. McClements W., Armstrong M., Keys R., and Lin M.A. Immunization with DNA vaccines encoding glycoprotein D or B, alone or in combination induces protective immunity in animal models of Herpes simplex virus-2 disease. Proc Natl Acad Sci USA 93 (1996) 11414-11420
19. Cho J.K., Cho J., Kim S.U., Kang H., Cho M.H., and Le H.H. Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs. Virus Res 86 (2002) 21-31
20. Sparks-Thissen R.L., Braaten D.C., Hildner K., Murphy T.L., Murphy K.M., and Virgin I.V.R. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNg. Virology 338 (2005) 201-208
21. Yamamoto K., Yamaguchi M., Miyasaka N., and Miura O. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor b2 subunit. Biochem Biophys Res Commun 310 (2003) 1188-1193
22. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Miura S., Jimbow K., et al. Induction of suppressor of cytokine signaling-3 by Herpes simplex virus Type 1 contributes to inhibition of the interferon signaling pathway. J Virol 78 12 (2004) 6282-6286